Durvalumab is classified as monoclonal antibodies and used to treat lung and a certain type of bladder and urinary tract cancer by helping patient’s immune systems fight against cancer.
Side Effects of Durvalumab(Imfinzi):
- Tiredness.
- Loss of appetite.
- Nausea.
- Constipation.
- Muscle/bone pain.
- Swelling hands/ankles/feet.
If any of these effects happen or get worse, tell your doctor right away.
Reviews
There are no reviews yet.